Category & trade
Primary
pharmaceutical-drugs · embed-ft 0.62
Tree path
Medical Health › Pharmaceutical Drugs
Group (tier-1)
Tech stack
AI readiness
AI training policy
allowed
Terms of Service
AI-bot protection
AI files
Compliance (GEO / GDPR)
TLD
Overview
Title
OXLUMO® (lumasiran) | Official Patient Website
Description
OXLUMO® (lumasiran) is the first FDA-approved prescription medication for the treatment of primary hyperoxaluria type 1 (PH1) by lowering oxalate in urine. See Important Safety Information on risk of injection site reactions.
Final URL
Language
en (html)
Scanned at
2026-06-25 17:07:28